Product Description: Ravidasvir hydrochloride (PPI-668 hydrochloride) is a pan-genotypic inhibitor for hepatitis C virus (HCV) NS5A protein. Ravidasvir hydrochloride inhibits the replication of HCV, with EC50 of 0.12, 0.01 and 1.14 nM, for HCV gt-1a, gt-1b, and gt-3a replicons, respectively. Ravidasvir hydrochloride exhibits good pharmacokinetic characters in rats[1].
Applications: COVID-19-anti-virus
Formula: C42H52Cl2N8O6
References: [1]Zhong M, et al., Discovery of ravidasvir (PPI-668) as a potent pan-genotypic HCV NS5A inhibitor. Bioorg Med Chem Lett. 2016 Sep 15;26(18):4508-4512.
CAS Number: 1303533-81-4
Molecular Weight: 835.82
Compound Purity: 99.94
Research Area: Infection
Solubility: DMSO : 125 mg/mL (ultrasonic)
Target: HCV